Reginelli JP - Search Results

1

A CHIP fellow's transition into practice: Building a complex coronary therapeutics program.

Riley RF, Henry TD, Kong JA, Reginelli JP, Kereiakes DJ, Grantham JA, Lombardi WL. Riley RF, et al. Among authors: reginelli jp. Catheter Cardiovasc Interv. 2020 Nov;96(5):1058-1064. doi: 10.1002/ccd.28599. Epub 2019 Nov 25. Catheter Cardiovasc Interv. 2020. PMID: 31763767

2

A quality framework for the role of invasive, non-interventional cardiologists in the present-day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement.

Mulukutla SR, Babb JD, Baran DA, Boudoulas KD, Feldman DN, Hall SA, Jennings HS 3rd, Kapur NK, Rao SV, Reginelli J, Schussler JM, Yang EH, Cigarroa JE. Mulukutla SR, et al. Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1356-1364. doi: 10.1002/ccd.27841. Epub 2018 Sep 27. Catheter Cardiovasc Interv. 2018. PMID: 30260064

3

Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration.

Casserly IP, Kereiakes DJ, Gray WA, Gibson PH, Lauer MA, Reginelli JP, Moliterno DJ. Casserly IP, et al. Among authors: reginelli jp. Thromb Res. 2004;113(2):115-21. doi: 10.1016/j.thromres.2004.02.012. Thromb Res. 2004. PMID: 15115666

4

Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting.

Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Abou-Chebl A, et al. Catheter Cardiovasc Interv. 2007 Apr 1;69(5):690-6. doi: 10.1002/ccd.20693. Catheter Cardiovasc Interv. 2007. PMID: 17377975

5

Adjunctive medical therapy for acute coronary syndromes.

Robbins M, Reginelli JP, Francis GS. Robbins M, et al. Among authors: reginelli jp. Cleve Clin J Med. 2000 Mar;67(3):205-13. doi: 10.3949/ccjm.67.3.205. Cleve Clin J Med. 2000. PMID: 10743308 Free article. Review.

6

Correlation of point-of-care ecarin clotting time versus activated clotting time with bivalirudin concentrations.

Cho L, Kottke-Marchant K, Lincoff AM, Roffi M, Reginelli JP, Kaldus T, Moliterno DJ. Cho L, et al. Among authors: reginelli jp. Am J Cardiol. 2003 May 1;91(9):1110-3. doi: 10.1016/s0002-9149(03)00159-0. Am J Cardiol. 2003. PMID: 12714157 Clinical Trial. No abstract available.

7

Unexpected mortality reduction with abciximab for in-stent restenosis.

Mukherjee D, Reginelli JP, Moliterno DJ, Yadav JS, Schneider JP, Raymond R, Whitlow PL, Franco I, Topol EJ, Ellis SG. Mukherjee D, et al. Among authors: reginelli jp. J Invasive Cardiol. 2000 Nov;12(11):540-4. J Invasive Cardiol. 2000. PMID: 11060563

8

Direct thrombin inhibitors for percutaneous coronary intervention in the current era of platelet glycoprotein IIb/IIIa inhibition.

Reginelli JP, Chew D. Reginelli JP, et al. J Interv Cardiol. 2002 Apr;15(2):141-6. doi: 10.1111/j.1540-8183.2002.tb01046.x. J Interv Cardiol. 2002. PMID: 12063809 Review. No abstract available.

9

Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment.

Abou-Chebl A, Yadav JS, Reginelli JP, Bajzer C, Bhatt D, Krieger DW. Abou-Chebl A, et al. Among authors: reginelli jp. J Am Coll Cardiol. 2004 May 5;43(9):1596-601. doi: 10.1016/j.jacc.2003.12.039. J Am Coll Cardiol. 2004. PMID: 15120817 Free article.

10

Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting.

Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro F, Yadav JS. Mukherjee D, et al. Am J Cardiol. 2001 Nov 1;88(9):1064-6. doi: 10.1016/s0002-9149(01)01996-8. Am J Cardiol. 2001. PMID: 11704015 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page